#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Immunodeficiency common variable Hyperinsulinism C3 glomerulopathy Leiomyosarcoma Candida infection Intracranial germ cell tumour Sjogren's syndrome Obesity Waldenstrom's macroglobulinaemia Graft versus host disease Brain stem glioma Breast cancer metastatic Cholestatic pruritus Alveolar rhabdomyosarcoma Familial hypertriglyceridaemia More trials…

    Learn about Rare Diseases

    Systemic sclerosis pulmonary – Diagnostics Carcinoid syndrome – Basic Information Chronic granulomatous disease – Life with Disease Epidermolysis bullosa – Trials in Disease Cystic fibrosis Sjogren’s syndrome – Diagnostics Shprintzen-Goldberg syndrome – Diagnostics Alport’s syndrome – Life with Disease Hairy cell leukaemia – Treatment Skin angiosarcoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tasipimidine Sodium Iodide Metamizole Cytisine Morphine Hydrochloride Levofloxacin Hemihydrate Cerebrolysin Concentrate A49 Tasimelteon Levocabastine Hydrochloride INOBRODIB HUMAN FIBROBLASTS TEDUGLUTIDE ABBV-CLS-628 Nebivolol Hydrochloride ZIMISLECEL LINAPRAZAN GLURATE Tulmimetostat Pravastatin Sodium Adrenaline Acid Tartrate Bp More therapies…

    Learn about Your Condition

    Transient ischaemic attack Epstein-Barr virus infection Myositis Myeloproliferative neoplasm Malignant oligodendroglioma Lennox-Gastaut syndrome Micrographic skin surgery Dystonic tremor Cardiovascular disorder Ovarian granulosa cell tumour Chorioretinitis Endometrial cancer stage II Epidermolysis bullosa Somatic symptom disorder Metastatic neoplasm More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • ORKA-001 in Patients with Moderate-to-Severe Plaque Psoriasis

    Not recruiting

    2 1
    Investigated Diseases:
    • Psoriasis
    Germany Spain

  • Phase 3 study of ianalumab plus standard drug combination in adults and adolescents with systemic lupus erythematosus

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Entecavir
    • Ianalumab
    • Tenofovir Disoproxil
    Bulgaria Czechia Hungary Poland Portugal Slovakia +1

  • Study of Lutetium (177Lu) Oxodotreotide, Carboplatin, Etoposide, and Atezolizumab in Newly Diagnosed Extensive Stage Small Cell Lung Cancer Patients

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Small cell lung cancer extensive stage
    Investigated Drugs:
    • Arginine Hydrochloride
    • Lysine Hydrochloride
    • Dotatate
    Austria Belgium Czechia France Germany Italy +2

  • Tulisokibart in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease

    Not recruiting

    2 1
    Investigated Diseases:
    • Systemic sclerosis pulmonary
    Investigated Drugs:
    • Tulisokibart
    Belgium France Germany Hungary Italy The Netherlands +2

  • Pharmacokinetics of Intravenous Lidocaine Hydrochloride in Young and Elderly Patients Undergoing Anesthesia

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Lidocaine Hydrochloride
    France

  • Baricitinib Compared with Adalimumab and Etanercept in Patients with Rheumatoid Arthritis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Etanercept
    • Adalimumab
    • Baricitinib
    Austria Belgium Czechia Denmark France Germany +9
Previous Page
1 … 914 915 916 917 918 … 1,675
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!